Home
Bone Therapeutics

Bone Therapeutics Market Share Analysis for November 2025

bone therapeutics is a bone cell therapy company specializing in addressing unmet medical needs in the field of bone fracture repair and bone fracture prevention. bone therapeutics develops both autologous and allogeneic innovative cell therapy products.

Health > Biotechnology and Pharmaceuticals

Domainbonetherapeutics.com

Year Founded2006

Employees51 - 200

Annual Revenue$1M - $2M

Bone Therapeutics

Bone Therapeutics (including company regionals)

bonetherapeutics.com

See more website traffic and engagement information

Bone Therapeutics Revenue up to November 2025 is 1M - 2M

revenue generated by Bone Therapeutics top domains

Bone Therapeutics top domains revenue over 3 years

Revenue for Bone Therapeutics top domains

bonetherapeutics.com1M - 2M

See more with Sales Intelligence

Total visits to Bone Therapeutics's top domains

Understand Bone Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

bonetherapeutics.com192.9K

See more with Sales Intelligence

Avg. visit duration in Bone Therapeutics's top domains

Analyze Bone Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

bonetherapeutics.com00:02:37

See more with Sales Intelligence

Avg. pageviews on Bone Therapeutics's top domains

See how Bone Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

bonetherapeutics.com1.91

See more with Sales Intelligence

Bone Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Bone Therapeutics

These are the website technologies, by industry, used by Bone Therapeutics top domains

Advertising (8)

DoubleClick

Payment & Currencies (8)

Cart Functionality

Mobile (6)

Meta Viewport

Conversion & Analytics (5)

Google Analytics

More Technologies

11

See all

News & Signals from Bone Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBone Therapeutics SA hired Anthony Ting as Chief Scientific Officer on Mar 20th '22.In March, 2021, Bone Therapeutics appointed the stem cell therapy industry veteran, Anthony Ting, PhD, as Chief Scientific Officer.

NewsBone Therapeutics SA expands offices to Louvain-la-Neuve Science Park in Mont-Saint-Guibert.Bone Therapeutics has relocated its corporate offices to the Louvain-la-Neuve Science Park in Mont-Saint-Guibert (Louvain-la-Neuve), Belgium.

NewsBone Therapeutics SA is developing iMSC platform generation on Jan 1st '22.Taking into account the proceeds of this private placement and the completion of the licensing agreement with Link Health, Bone Therapeutics anticipates having a runway into Q4 2022, enhancing further development of its lead asset, ALLOB, and its next generation iMSC platform.